DJ Elevance Health Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) rose 3.05% to $422.04 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.76% to 5,572.07 and Dow Jones Industrial Average falling 1.14% to 41,433.48.
This was the stock's sixth consecutive day of gains.
Elevance Health Inc. closed 25.60% below its 52-week high of $567.26, which the company reached on September 3rd.
The stock outperformed some of its competitors Tuesday, as UnitedHealth Group Inc. $(UNH)$ rose 1.21% to $486.04, Cigna Group $(CI)$ fell 2.70% to $317.87, and Humana Inc. $(HUM.UK)$ fell 0.42% to $250.20.
Trading volume (3.1 M) eclipsed its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 11, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 11, 2025 16:40 ET (20:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。